Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis

Author(s):
Sieper, J.; Heijde, D. van der; Dougados, M.; Brown, L.S.; Lavie, F.; Pangan, A.L.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-05-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2012), Vol. 71, no. 5, p. 700-706
hdl
1887/118322
doi
10.1136/annrheumdis-2011-200358